Accessibility Menu
McKesson logo

McKesson(NYSE) MCK

Current Price$841.03
Market Cap$98.45BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1994)+6,636%
5 Year+326%
1 Year+19%
1 Month+10%
McKesson last closing stock price
MetricPriceDate
Last closeUSD 840.902026-07-24
McKesson stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.06%USD 841.392026-07-17
1 month+9.7%USD 766.552026-06-24
3 month+1.66%USD 827.202026-04-24
Year to date+2.71%USD 818.702025-12-31
1 year+18.89%USD 707.312025-07-24
3 year+107.28%USD 405.692023-07-25
5 year+326.37%USD 197.222021-07-23
Since inception+6,635.75%USD 12.481994-11-10

McKesson Financials at a Glance

Market Cap

$98.45BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$403.43B

Net Income (TTM)

$4.76B

EPS (TTM)

$38.47

P/E Ratio

21.86

Dividend

$3.28

Beta (Volatility)

0.23 (Low)

Price

$841.03

Volume

104,599

Open

$829.93

Previous Close

$841.03

Daily Range

$828.93 - $843.47

52-Week Range

$637.00 - $999.00

Estimated Earnings Date

Aug 5, 2026

MCK News

A magnifying glass held over a sheet detailing company finances.

What Is the Fortune 100?

Matt DiLalloNov 19, 2025
Man presenting data to colleagues

What Is the Fortune 500?

Kristi WaterworthOct 12, 2025
Child receiving a vaccination shot from a healthcare professional

Why McKesson Stock Bumped Modestly Higher Today

Eric VolkmanMay 9, 2025
Hospital-healthcare-nurse-patient.jpg

McKesson Exceeds EPS, Q3 Profit Surges

Motley Fool Markets TeamFeb 5, 2025
GettyImages-928320744-600x372-132bd13.jpg

McKesson's Fiscal Q2 EPS Tops Forecast

Motley Fool Markets TeamNov 6, 2024
GettyImages-1342134425.jpg

McKesson: EPS Soars, Revenue Misses

Motley Fool Markets TeamAug 7, 2024
medical staff talk with management

This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks

Alex CarchidiDec 4, 2023
surgical gloves and surgical lights in the operating room

2 Best Buffett Stocks to Buy for the Long Haul

James HalleyJun 26, 2023
Page 1

MCK: Motley Fool Moneyball Superscore

78

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About McKesson

McKesson delivers medicines and medical supplies to pharmacies, hospitals, and clinics. Its technology helps doctors and pharmacies manage prescriptions and patient care. The company’s services support healthcare providers in treating patients efficiently and safely.

Pills, Tech, and Bandages: What McKesson Sells

  • U.S. Pharmaceutical (91.9% of total revenue for the three months ended June 30, 2025): Distributes prescription and over-the-counter drugs to pharmacies and hospitals.
  • Prescription Technology Solutions (1.5% of total revenue for the three months ended June 30, 2025): Offers software and logistics to help pharmacies and drug companies manage prescriptions and insurance approvals.
  • Medical-Surgical Solutions (2.8% of total revenue for the three months ended June 30, 2025): Supplies medical equipment and products to clinics, surgery centers, and nursing homes.
  • International (3.8% of total revenue for the three months ended June 30, 2025): Provides drug distribution and pharmacy services in Canada and Norway.

Growth Spurts and New Directions

  • Acquired PRISM Vision Holdings (2025) to expand in eye care management.
  • Bought 70% of Core Ventures (2025) to grow in oncology services.
  • Divested Canadian retail businesses (2024) and agreed to sell Norwegian operations (2025).
  • Announced plan in 2025 to separate Medical-Surgical Solutions into a new company.
  • Invested in technology upgrades and restructuring since 2024 to modernize operations.

Why McKesson Stands Out in the Crowd

McKesson’s large U.S. distribution network connects drug makers with pharmacies and hospitals nationwide. Its technology services help healthcare providers manage prescriptions and improve patient access to medicines. The company’s mix of logistics, software, and specialty care support gives it a broad role in the healthcare supply chain.

Five Things You Need to Know

  • Revenue was $103.15 billion in Q2 2026, up 10.1% from Q2 2025.
  • Gross profit reached $3.54 billion in Q2 2026, up 12.6% year-over-year.
  • Net income was $1.11 billion in Q2 2026, up 360.6% from Q2 2025.

Bottom Line

McKesson has evolved from a drug distributor to a diversified healthcare services provider. Its scale, technology, and specialty care focus support its central role in the healthcare system.

AI Generated • Apr 16, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

43,000

CEO

Brian Scott Tyler, PhD

Website

www.mckesson.com

Headquarters

Irving, TX 75039, US

MCK Financials

Key Financial Metrics (TTM)

Gross Margin

3.61%

Operating Margin

1.58%

Net Income Margin

1.18%

Return on Equity

-265.44%

Return on Capital

100.19%

Return on Assets

5.78%

Earnings Yield

4.57%

Dividend Yield

0.39%

Payout Ratio

8.00%

Stock Overview

Market Cap

$98.45BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

117.08M

Volume

104.60K

Avg. Volume

1.18M

Financials (TTM)

Gross Profit

$14.55B

Operating Income

$6.37B

EBITDA

$7.02B

Operating Cash Flow

$6.16B

Capital Expenditure

-$219.00M

Free Cash Flow

$5.94B

Cash & ST Invst.

$3.98B

Total Debt

$8.61B

McKesson Performance Analysis

McKesson annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 276,711,000,0004.8%
20242024-03-31USD 308,951,000,00011.7%
20252025-03-31USD 359,051,000,00016.2%
20262026-03-31USD 403,430,000,00012.4%
McKesson sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-307.7%
Q22025-09-305.4%
Q32025-12-312.9%
Q42026-03-31-9.3%
McKesson annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD 25.04246.3%
20242024-03-31USD 22.39-10.6%
20252025-03-31USD 25.7214.9%
20262026-03-31USD 38.3749.2%
McKesson sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30-37.6%
Q22025-09-3042.7%
Q32025-12-317.5%
Q42026-03-3143.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

$96.30B

+6.0%

Gross Profit

$4.04B

+38.5%

Gross Margin

4.20%

N/A

Market Cap

$98.45BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.29M

N/A

Employees

43,000

N/A

Net Income

$1.68B

+33.5%

EBITDA

$2.26B

+32.1%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

$3.98B

-30.2%

Total Debt

$8.61B

+16.6%

Accounts Receivable

$27.99B

+9.1%

Inventory

$24.21B

+5.2%

Long Term Debt

$7.06B

+18.8%

Short Term Debt

$1.55B

+7.2%

Return on Assets

5.78%

N/A

Return on Invested Capital

41.62%

N/A

Free Cash Flow

$3.31B

-55.7%

Operating Cash Flow

$3.42B

-55.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GSKGSK plc
$51.35+1.20%
SNYSanofi
$43.35-0.02%
MDTMedtronic plc
$83.21+1.46%
HCAHCA Healthcare, Inc.
$382.19+1.51%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
TAT&T
$24.13+0.05%

Questions About MCK

What is the current price of McKesson?

McKesson is trading at $841.03 per share.

What is the 52-week range for McKesson?

Over the past 52 weeks, McKesson has traded between $637.00 and $999.00.

How much debt does McKesson have?

As of the most recent reporting period, McKesson reported total debt of $8.61B.

How much cash does McKesson have on hand?

McKesson reported $4.07B in cash and cash equivalents in its most recent financial results.

What is McKesson’s dividend yield?

McKesson currently has a dividend yield of 0.39%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services